Ruggeri M - Search Results

1

The minimum clinically important difference for EQ-5D index: a critical review.

Coretti S, Ruggeri M, McNamee P. Coretti S, et al. Among authors: ruggeri m. Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33. doi: 10.1586/14737167.2014.894462. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24625040 Review.

2

Economic assessment of eltrombopag in the treatment of thrombocytopenia.

Romano F, Ruggeri M, Coretti S, Giannini EG, Sacchini D, Annichiarico BE, Marchetti M, Rodeghiero F, Lidonnici D. Romano F, et al. Among authors: ruggeri m. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):713-20. doi: 10.1586/14737167.2015.1028373. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 26176754

3

Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.

Ruggeri M, Basile M, Coretti S, Drago C, Cicchetti A. Ruggeri M, et al. Appl Health Econ Health Policy. 2017 Aug;15(4):479-490. doi: 10.1007/s40258-017-0311-4. Appl Health Econ Health Policy. 2017. PMID: 28197805

4

Economic assessment of an anti-HCV screening program in Italy.

Ruggeri M, Coretti S, Gasbarrini A, Cicchetti A. Ruggeri M, et al. Value Health. 2013 Sep-Oct;16(6):965-72. doi: 10.1016/j.jval.2013.07.005. Value Health. 2013. PMID: 24041346 Free article.

5

Do Probability and Certainty Equivalent Techniques Lead to Inconsistent Results? Evidence from Gambles Involving Life-Years and Quality of Life.

Ruggeri M, Coretti S. Ruggeri M, et al. Value Health. 2015 Jun;18(4):413-24. doi: 10.1016/j.jval.2014.12.019. Epub 2015 Apr 15. Value Health. 2015. PMID: 26091595 Free article.

6

Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review.

Ruggeri M, Manca A, Coretti S, Codella P, Iacopino V, Romano F, Mascia D, Orlando V, Cicchetti A. Ruggeri M, et al. Value Health. 2015 Jul;18(5):709-20. doi: 10.1016/j.jval.2015.03.1795. Value Health. 2015. PMID: 26297100 Free article. Review.

7

Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort.

Ruggeri M, Coretti S, Romano F, Kondili LA, Vella S, Cicchetti A. Ruggeri M, et al. Value Health. 2018 Jul;21(7):783-791. doi: 10.1016/j.jval.2017.10.021. Epub 2017 Dec 6. Value Health. 2018. PMID: 30005750 Free article.

8

Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy.

Ruggeri M, Romano F, Basile M, Coretti S, Rolli FR, Drago C, Cicchetti A. Ruggeri M, et al. Appl Health Econ Health Policy. 2018 Oct;16(5):711-722. doi: 10.1007/s40258-018-0410-x. Appl Health Econ Health Policy. 2018. PMID: 30039348

9

Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy.

Coretti S, Ruggeri M, Codella P. Coretti S, et al. Among authors: ruggeri m. Value Health. 2014 Nov;17(7):A511. doi: 10.1016/j.jval.2014.08.1572. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201575 Free article. No abstract available.

10

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs.

Menditto E, Orlando V, Coretti S, Putignano D, Fiorentino D, Ruggeri M. Menditto E, et al. Among authors: ruggeri m. Clinicoecon Outcomes Res. 2015 Nov 11;7:575-81. doi: 10.2147/CEOR.S88531. eCollection 2015. Clinicoecon Outcomes Res. 2015. PMID: 26635482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

835 results

Search Page

Filters